We Innovate

Providing IPS-based Platforms for Pharma & Research Institutions


    Printing plates at a larger order of magnitude to lower cost


    3D Hydrogel scaffold, mimics physiologic environment


    Accelerate growth/differentiation through engineering the extra cellular matrix


    Plates can represent a population or an individual

Why StemoniX?

We grow, differentiate, and print organ cells from skin cells, in a way that makes them biologically accurate, to better predict their toxicity and improve efficacy.

Blue: DNA staining of fibroblasts highlighting their nuclei

Red: Phalloidin staining of Actin Cytoskeleton

Our technology includes the ability to create a variety of organ cells that can mimic diseases to help accelerate the discovery of new cures in the areas of heart disease, dementia and neuromuscular diseases.

Why StemoniX?

About Us

Our team and scientific board have vetted StemoniX IP with over $200M and a track record of success


Meet the StemoniX Team

MS, MBA, PMP, PgMP, Ping has formed and led teams to producing world-changing devices. His expertise focuses on merging core intellectual property from startups to F100 corporations.
Ping Yeh | Founder & CEO
Dr. Bob Petcavich, Cofounder & Chief Science Advisor of StemoniX, is a successful serial inventor and entrepreneur, holding nearly 60 patents.
Robert Petcavich | Co-founder
PhD in cell-based assays for high throughput cancer drug discovery. A leader at the Dept. of Medicine & Division of Cardiology at University of California, San Diego.
Fabian Zanella | Head of Cell Biology
MD MBA FACEP, Dr. Khaleghi has led the personalized medicine process for WellnessFX as their medical director. He has also served as CMIO of the Noble Health System, and published 6 health books.
Murdoc Khaleghi | Chief Medical Officer


Latest StemoniX News

  • Aug, 16

    – San Diego, CA “1 Billion Cells, 1 Lot, 1 Week” – Cell Applications and StemoniX Accelerate Life Science Research with Mass Production of Human Induced Pluripotent Stem Cells Cell Applications, Inc. and StemoniX announced a partnership that will allow them to produce up to one billion human induced pluripotent stem cells (HiPSC) from one […]

    Read more
    Aug, 16

    – Minneapolis, MN “MN Cup Semifinalists: StemoniX” Meet StemoniX, a Life Science/Health IT Division semifinalist! Who are you and what do you do? My name is Ping Yeh and I’m co-founder and CEO of StemoniX and I lead a team of scientists, engineers and physicians who make heart and brain cells from skin to accelerate […]

    Read more
  • Aug, 4

    – Minneapolis, MN “Micro-organ startup StemoniX raises capital, plots Twin Cities expansion” The business can create tiny organs that drug companies can use for testing. A startup producing miniature organs for drug-development research has raised about $500,000 in capital as its scouts for sites to expand its Twin Cities operations. Ping Yeh, who held leadership […]

    Read more
    Jun, 24

    – San Diego, California “Would This New Treatment Save Me, or Kill Me?” A Q&A with San Diego entrepreneur and cancer survivor Ping Yeh Ping Yeh is the co-founder of StemoniX, a local startup that uses 3-D printing to create stem cells from skin cells at high volumes, which pharmaceutical companies can use to test […]

    Read more
  • Jun, 15

    – San Diego, California StemoniX partners with Cell Applications The leader in primary cells for over 20 years, Cell Applications together with StemoniX are changing the game of human induced pluripotent stem cells. StemoniX is a cutting-edge biotechnology company that is leading the development and manufacturing of Human Induced Pluripotent Stem Cells (HiPSCs) They generate […]

    Read more
    Apr, 4

    – San Diego, California STEMONIX WINS EVONEXUS DEMO DAY! “StemoniX – is revolutionizing stem cell based research and drug screening, leading to a new era of personalized and regenerative medicine – was voted by the audience as the Winner of Demo Day. LeadCrunch by Englue provides high precision B2B leads using artificial intelligence – was […]

    Read more

StemoniX Connections:

Please leave this field empty.